Epiliquid Holding, Inc

This study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 100 people with liver cancer and 100 people with liver cirrhosis (but no cancer). If successf…

This study is testing a new blood test called Delta-HLD to see how well it can detect colorectal cancer in average-risk people aged 45 to 75 who are already scheduled for a screening colonoscopy. The colonoscopy results will be used as the gold standard to compare the blood test'…